ESC 365 - Protecting the patient undergoing lower extremity revascularization for symptomatic PAD.

ESC Premium Access

Protecting the patient undergoing lower extremity revascularization for symptomatic PAD.

Session: Towards a new standard of care in coronary and peripheral artery disease: from trial results to guidelines and beyond

Topic: Treatment

Speaker: Doctor M. Bonaca (Aurora, US)

Sponsored by Bayer AG

Event: ESC Congress 2020

Congress Presentation

About the speaker

Doctor Marc Bonaca

University of Colorado Anschutz Medical Campus, Aurora (United States of America)

25 presentations

1 follower

5 more presentations in this session

Welcome and introduction.

Speaker: Professor R. Welsh (Edmonton, CA)

Protecting the patient that needs more: moving from ‘stable coronary artery disease’ to ‘chronic coronary syndromes’.

Speaker: Professor J. Steffel (Zurich, CH)

How can we protect patients long-term after a percutaneous coronary intervention (PCI)?

Speaker: Professor R. Welsh (Edmonton, CA)

Optimizing protection for patients with symptomatic chronic peripheral artery disease.

Speaker: Professor M. Brodmann (Graz, AT)

Live Questions and Answers and closing.

Access the full session

Towards a new standard of care in coronary and peripheral artery disease: from trial results to guidelines and beyond

Speakers: Doctor M. Bonaca, Professor R. Welsh, Professor J. Steffel, Professor R. Welsh, Professor M. Brodmann

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

Related content

HFA Premium Access

SGLT2i for HFpEF - rebuttal and discussion.

23 May 2022

Open Access

Expanding evidence on SGLT2i: where are we now and what can we expect?

22 May 2022

Open Access

The clinical challenges of initiating guideline-recommended therapy in HFrEF.

22 May 2022

ESC 365 is supported by